Related Experiment Video
Updated: Jul 5, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
Employees' need for speed: methamphetamine in the workplace
Suzanne M Crampton1, Jitendra M Mishra, David W Zerfas
1Grand Valley State University, 401 W. Fulton, Grand Rapids, MI 49504, USA. cramptos@gvsu.edu
Methamphetamine poses significant risks to health and workplaces. Training employees to recognize and respond to these hazards can improve overall emergency preparedness.
Area of Science:
- Public Health
- Occupational Safety
- Environmental Science
Background:
- Methamphetamine is a highly addictive substance with widespread negative impacts.
- These impacts affect individual health, family structures, businesses, social services, and the environment.
- The pervasive nature of methamphetamine hazards necessitates organizational preparedness.
Purpose of the Study:
- To highlight the broad risks associated with methamphetamine.
- To emphasize the need for organizations to update policies and emergency plans.
- To advocate for employee training in identifying and managing methamphetamine-related hazards.
Main Methods:
- Review of the multifaceted impacts of methamphetamine.
- Analysis of organizational policy and emergency action plan relevance.
- Proposal for targeted employee training protocols.
Main Results:
- Methamphetamine addiction creates significant challenges across multiple societal domains.
- Existing organizational policies and emergency plans may be insufficient to address these specific hazards.
- Employee training is identified as a key strategy for mitigating risks.
Conclusions:
- Organizations must proactively update policies and emergency plans to address methamphetamine hazards.
- Implementing comprehensive employee training enhances the management of methamphetamine-related risks.
- Improved hazard recognition and response contribute to better overall workplace safety and emergency management.
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drug Abuse and Addiction: Pharmacological Phenomena
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

